Open AccessComparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study
Author(s) -
Andrew R. Zullo,
Y. Lee,
Christine W. Lary,
Lori A. Daiello,
Douglas P. Kiel,
Sarah D. Berry
Publication year - 2021
Publication title -
osteoporosis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 170
eISSN - 1433-2965
pISSN - 0937-941X
DOI - 10.1007/s00198-020-05732-2
Subject(s) - teriparatide , denosumab , medicine , zoledronic acid , osteoporosis , hip fracture , retrospective cohort study , cohort , cohort study , population , physical therapy , bone mineral , environmental health
The comparative effects of zoledronic acid, denosumab, and teriparatide for preventing hip fractures in frail older adults, especially those in nursing homes, were unknown. We found that denosumab and zoledronic acid may be as effective as teriparatide for hip fracture prevention in nursing home residents.